Edge Therapeutics, Inc. Intellectual Property Contracts & Agreements

6 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement between Merck KGaA and PDS Biotechnology Corporation (December 30, 2022)
License Agreements
Edge Therapeutics, Inc.
Biotechnology
NJ
2023
Amended and Restated Preclinical/Clinical Collaboration and License Agreement between PDS Biotechnology Corporation and Farmacore Biotechnology (November 30, 2020)
License Agreements
Edge Therapeutics, Inc.
Biotechnology
NJ
2022
Option Agreement Between University of Georgia Research Foundation, Inc. and PDS Biotechnology Corporation
License Agreements
Edge Therapeutics, Inc.
Biotechnology
GA
2022
Non-Exclusive Patent License Agreement between National Cancer Institute (NIH) and PDS Biotechnology Corporation
License Agreements
Edge Therapeutics, Inc.
Biotechnology
2022
Amendment No. 1 to License Agreement between Evonik Corporation and Edge Therapeutics, Inc.
License Agreements
Edge Therapeutics, Inc.
Biotechnology
2015
License Agreement between SurModics Pharmaceuticals, Inc. and Edge Therapeutics, Inc. dated October 20, 2010
License Agreements
Edge Therapeutics, Inc.
Biotechnology
NJ
2015